Literature DB >> 18178862

Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency.

Jenny Miu1, Andrew J Mitchell, Marcus Müller, Sally L Carter, Peter M Manders, James A McQuillan, Bernadette M Saunders, Helen J Ball, Bao Lu, Iain L Campbell, Nicholas H Hunt.   

Abstract

Cerebral malaria (CM) can be a fatal manifestation of Plasmodium falciparum infection. Using murine models of malaria, we found much greater up-regulation of a number of chemokine mRNAs, including those for CXCR3 and its ligands, in the brain during fatal murine CM (FMCM) than in a model of non-CM. Expression of CXCL9 and CXCL10 RNA was localized predominantly to the cerebral microvessels and in adjacent glial cells, while expression of CCL5 was restricted mainly to infiltrating lymphocytes. The majority of mice deficient in CXCR3 were found to be protected from FMCM, and this protection was associated with a reduction in the number of CD8+ T cells in brain vessels as well as reduced expression of perforin and FasL mRNA. Adoptive transfer of CD8+ cells from C57BL/6 mice with FMCM abrogated this protection in CXCR3-/- mice. Moreover, there were decreased mRNA levels for the proinflammatory cytokines IFN-gamma and lymphotoxin-alpha in the brains of mice protected from FMCM. These data suggest a role for CXCR3 in the pathogenesis of FMCM through the recruitment and activation of pathogenic CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178862     DOI: 10.4049/jimmunol.180.2.1217

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.

Authors:  Brittany A Riggle; Sanhita Sinharay; William Schreiber-Stainthorp; Jeeva P Munasinghe; Dragan Maric; Eva Prchalova; Barbara S Slusher; Jonathan D Powell; Louis H Miller; Susan K Pierce; Dima A Hammoud
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities.

Authors:  Chek Meng Poh; Shanshan W Howland; Gijsbert M Grotenbreg; Laurent Rénia
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.

Authors:  Jintao Guo; James A McQuillan; Belinda Yau; Gregory S Tullo; Carole A Long; Patrick Bertolino; Ben Roediger; Wolfgang Weninger; Gregory A Taylor; Nicholas H Hunt; Helen J Ball; Andrew J Mitchell
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

Review 4.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

5.  Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.

Authors:  Gabriele S V Campanella; Andrew M Tager; Joseph K El Khoury; Seddon Y Thomas; Tabitha A Abrazinski; Lindsay A Manice; Richard A Colvin; Andrew D Luster
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

Review 6.  Natural regulatory T cells in malaria: host or parasite allies?

Authors:  Diana S Hansen; Louis Schofield
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

7.  Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis.

Authors:  Jenny Miu; Nicholas H Hunt; Helen J Ball
Journal:  Infect Immun       Date:  2008-02-25       Impact factor: 3.441

8.  Platelet factor 4 mediates inflammation in experimental cerebral malaria.

Authors:  Kalyan Srivastava; Ian A Cockburn; AnneMarie Swaim; Laura E Thompson; Abhai Tripathi; Craig A Fletcher; Erin M Shirk; Henry Sun; M Anna Kowalska; Karen Fox-Talbot; David Sullivan; Fidel Zavala; Craig N Morrell
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

9.  IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection.

Authors:  Catherine Q Nie; Nicholas J Bernard; M Ursula Norman; Fiona H Amante; Rachel J Lundie; Brendan S Crabb; William R Heath; Christian R Engwerda; Michael J Hickey; Louis Schofield; Diana S Hansen
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

10.  Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.

Authors:  Miranda S Oakley; Victoria Majam; Babita Mahajan; Noel Gerald; Vivek Anantharaman; Jerrold M Ward; Lawrence J Faucette; Thomas F McCutchan; Hong Zheng; Masaki Terabe; Jay A Berzofsky; L Aravind; Sanjai Kumar
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.